NDATOPICALCREAM
Approved
Oct 1965
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
4/8 — Partial
CORDRAN SP (flurandrenolide) by Molecular Devices is corticosteroid hormone receptor agonists [moa]. Approved for corticosteroid [epc]. First approved in 1965.
Drug data last refreshed 19h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CORDRAN SP is a topical corticosteroid cream containing flurandrenolide, a synthetic corticosteroid that acts as a hormone receptor agonist. It is indicated for inflammatory and pruritic dermatological conditions and works by stabilizing cellular and lysosomal membranes to reduce inflammation, itching, and vasodilation. The product has been approved since 1965 and represents a mature, well-established therapeutic agent in dermatology.
LOE Approaching
As a legacy topical corticosteroid approaching loss of exclusivity with minimal documented spending, CORDRAN SP likely operates with a lean commercial team focused on cost management and defending base business against generic erosion.
Mechanism of Action
Corticosteroid Hormone Receptor Agonists
Pharmacologic Class:
Corticosteroid
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
CORDRAN SP offers limited career development opportunities given its LOE-approaching status and minimal commercial investment; roles are primarily defensive and focused on maintaining market share against generics and managing a shrinking revenue base. Career advancement on this product would likely require lateral movement to growth-stage assets or transition to portfolio management responsibilities across a dermatology franchise.
Brand Manager
Worked on CORDRAN SP at Molecular Devices? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.